DRUG

Conviction 55HealthcareScan · Mon, Aug 10, 2026

DRUG$80.79+1.84%

ResistanceSupportVol 14

Vol MA14 224.35K

May 11May 28Jun 16Jul 6Jul 23Aug 10

BRIGHT MINDS BIOSCIENCES INC.Biotechnologywww.brightmindsbio.com ↗

Price80.79

Change+1.84%

Gap-1.37%

Rel volume2.10×

Avg volume226.14K

Avg $ vol16.98M

SMA 2075.26

SMA 5071.12

SMA 20076.06

Price vs 50+13.59%

Price vs 200+6.21%

MA stackmixed

50/200 cross—

Supertrendup · 68.91

RSI (14)62

MACD hist0.73

MACD crossbull · 4d

Stoch %K / %D84 / 81

ADX (14)18

+DI / −DI22 / 13

RSI divergence—

MACD divergence—

ATR %+5.34%

ADR %5.38%

52w high95.99

52w low38.75

From 52w high-15.83%

Above 52w low+108.49%

New 52w highNo

SqueezeOn · 5d

Bollinger width16.41%

%B0.95

Donchian pos84.44%

Donchian high83.00

Donchian low68.80

AVWAP (52w high)77.11

vs AVWAP high+4.77%

AVWAP (52w low)73.20

vs AVWAP low+10.37%

OBV trendUp

Chaikin MF (20)-0.01

Today vs 20d2.10×

Avg vol (14d)224.35K

Avg vol (20d)226.14K

Avg $ vol (20d)16.98M

Market cap—

RS 3m (vs SPY)-16.38%

RS 6m (vs SPY)-5.56%

RS line new highNo

Trend template6/8

Technical rank68.3

1 week+9.50%

1 month+3.79%

3 months-5.51%

6 months+6.34%

1 year+132.16%

YTD-3.20%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target182.50

Target upside131.07%

Analyst ratingBuy

Institutional95.28%

Ent. value357.31M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out9.73M

Employees25

ListedMon, Mar 8, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank68.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance79.03

Support59.74

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in DRUG

All disclosures →

No recent disclosed trades by Congress in DRUG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DRUG

No recent insider (Form 4) filings in DRUG. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DRUG · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.